|

Antiplatelet therapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Assistance Publique - Hôpitaux de Paris1

Indications

  • Cryptogenic Ischemic Stroke1
  • Patent Foramen Ovale1
  • Heart Disease1

Other1 trial

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.